CARLSBAD, Calif., April 13, 2011 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will host a Technology Day for investors and analysts on Thursday, May 12, 2011 from 8:30 a.m. to 11:30 a.m. Eastern Time at the Grand Hyatt New York Hotel in New York, New York. Registration for the event will begin at 8:00 a.m. Eastern Time.
Dirk Kuyper, the Company’s President and Chief Executive Officer, will host the meeting. During the meeting Mr. Kuyper will provide updates on the Company’s strategy and product pipeline. The agenda will include presentations from several leading spine surgeons to discuss key spine market segments and the Company’s product offerings. In addition, several leaders of the Company’s business units will host product demonstrations. Following the demonstrations there will be a question and answer session.
A live audio webcast of the presentation of the Alphatec Spine Technology Day will be accessible through the Company’s investor relations website at www.alphatecspine.com. An archived edition of the presentation will be available later that day and will be available for at least 30 days afterwards.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company’s mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient’s quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its subsidiary, Scient’x S.A., via a direct salesforce in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc., and through Scient’x’s distributors in China, Korea and Australia.
The Alphatec Holdings, Inc. logo is available athttp://www.globenewswire.com/newsroom/prs/?pkgid=3520